Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prev close 3.82 · gapped above the open, then crossed back over prior close. High/low 3.89 at 9:30 am ET, 3.60 at 2:00 pm ET.
Minerva Neurosciences, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
Sources
sec edgar · verbatim disclosureEach tie, with the sentence that disclosed it. Open a row for the wording and the filing it came from.
“In January 2021, we sold our rights to these potential royalties to Royalty Pharma plc ("Royalty Pharma") for a $60 million cash payment and up to an additional $95 million in potential future milestone payments, subject to completion of Phase 3 trials by Janssen and regulatory approvals.”
FILING10-K0001193125-26-101117cik 0001598646
“Under the terms of the agreement, Catalent manufactures and packages the finished dose form of roluperidone at its facility in Schorndorf, Germany.”
FILING10-K0001193125-26-101117cik 0001598646
“Under the terms of the Roluperidone License Agreement, we acquired an exclusive license to the lead compound known as CYR-101 (subsequently renamed MIN-101 and roluperidone), and other compounds with a similar structure and intended purpose and other data included within the valid claims of certain patents licensed to us under the Roluperidone License Agreement.”
FILING10-K0001193125-26-101117cik 0001598646
“Commercial Supply Agreement by and between the Registrant and Catalent Germany Schorndorf GmbH, dated September 18, 2019”
FILING10-K0001193125-26-101117cik 0001598646
“On November 14, 2025, the Company entered into a consulting agreement (the "Consulting Agreement") with Dr. Inderjit Kaul, one of its directors.”
FILING10-K0001193125-26-101117cik 0001598646
“In addition, we are or have engaged with a number of consultants and companies, including Pharma Partnering in Research & Strategy SAS ("PPRS"), that provide expertise in the key functions involved with the development of our products.”
FILING10-K0001193125-26-101117cik 0001598646
“On October 11, 2022, the Company entered into an office lease agreement with Regus to lease office space located at 1500 District Avenue, Burlington, MA 01803.”
FILING10-K0001193125-26-101117cik 0001598646
“As a result of our collaboration with Janssen, we were entitled to collect royalties in the mid-single digits on potential future worldwide sales of seltorexant in certain indications, with no further financial obligations to Janssen.”
FILING10-K0001193125-26-101117cik 0001598646
Watchlist prices, news filtered to it, and its next report on your desk.
Minerva Neurosciences, Inc. has 6 disclosed suppliers and 2 disclosed customers. Each one is named in an SEC filing, either Minerva Neurosciences, Inc.’s own annual report or the counterparty’s, and carries the sentence that discloses it.
NERV (Minerva Neurosciences, Inc.) has 6 disclosed suppliers and 2 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: RPRX −0.04%, in healthcare.